FdaApplication
NDA 214155
Identifiers
- fda_app_no: NDA214155
Properties
| Property | Value |
|---|---|
| applicant_name | MELINTA THERAPEUTICS LLC |
| application_type | NDA |
| approval_date | 2021-03-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KIMYRSA | ORITAVANCIN DIPHOSPHATE | EQ 1.2GM BASE/VIAL | POWDER;INTRAVENOUS |
1 product